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In opening the meeting, the representative of ECLAC thanked 
the Cuban delegation for hosting the workshop and outlined the role 
of the Caribbean Council for Science and Technology (CCST) in the 
promotion of information exchange, the fostering of technical 
assistance among the countries of the region and the bringing together 
of scientists in a search for solutions to common problems.
The meeting xias.. addressed by Dr. Ernie Brünings of Suriname, in 
his capacity as Chairman of CCST. Some of the aspects of the work 
programme of CCST were outlined and the hope was expressed that through 
co-operative efforts the scienfific and technological base in the 
region could be strengthened and thus meet the region’s needs and 
reduce dependence on the outside world. This was the key to 
development.
The feature address was given by Dr. Jorge Antelo, First Vice- 
Minister in the Ministry of Health of Cuba.
The format of this report is as follows: the major points of
each theme are presented together with the pertinent questions raised 
in the discussion period folloxved by Conclusions and Recommendations 
agreed to for further action.
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The first session of the meeting dealt with "An Overview of the 
Pharmaceutical Sector in the Caribbean (CARICOM) incorporating:
(a) Role of Transnational Corporations; (b) International Patent 
Systems"» This paper was presented by the CARICOM Secretariat and 
delivered by Dr. Kumariah Balasubramaniam and Dr» George Boyd,
The main points were as follows:
Prior to the achievement of political independence within the 
last 20 to 30 years, the health services in the Caribbean were based 
on the Colonial system of high technology hospital-based curative 
medical care. Subsequent to Independence, Governments have emphasised 
primary health care but in these States economies of scale do not 
operate because of their small sizes and the weakness of the purchasing 
system in the area. In most of the lesser developed countries, 
a relatively large proportion of the G.D»P, 2.16 percent, is spent 
on the importation of pharmaceuticals, a figure much greater than the 
world average which is 0.73 percent. Additionally, there is a wide 
variation in the unit price of drugs, both within and between countries. 
This occurs even in those countries vjhich have an Installed capacity 
for producing many forms of pharmaceuticals but are unable to penetrate 
the market.
In developing countries the heavy dependence on pharmaceutical 








The consensus of opinion of various United Nations bodies which 
have analysed in depth the existing Industrial property systems is 
that the Paris Convention has a negative impact on Third World 
Countries, since the principle of equality protects the monopolistic 
interests of patent holders« Local legislation can be used to 
lessen the impact of patents.
Trademarks and Promotion
The impact of trademarks is even greater than patents since this 
lasts for the life of the product. Although Caribbean Health Ministers 
have advised that there should be a shift in usage from brand name 
to generic drugs, this has not been achieved.
In shifting to generic drugs, the efficacy of these drugs must 
be assured by quality-control measures.
A regional drug testing facility for all marketed drugs has 
recently been established. Currently, CARICOM has formulated a 
list of all drugs imported into the region and it is proposed to 
prepare a formulary which will reduce the present multiplicity of 
drugs to those considered essential.
Additionally, Governments need to educate doctors and public 
health workers in this regard and to encourage the prescribing of 
generic drugs. A need exists for suitable drug legislation and for 
countries to have drug/therapeutic committees to examine the 
importation of drugs. National policies need to mesh with overall 
regional policies« In this respect, CARICOM has proposed a Joint 
Caribbean Authority for the Registration of Drugs (JOCARD)«
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A great deal of the discussion on the presentation centred on 
the patent system with two diametric concerns being voiced. One 
was for no protection of patents for pharmaceutical products and 
the other was for protection by patents against international piracy 
of locally produced industrial property. The opinion on these was 
that countries with technology to sell would be protected by the use 
of patents, but that those which were buyers of technology would be 
better served without patents.
Queries liere raised v/ith respect to a lack of information and 
expertise on patents. In this regard, participants were informed on 
the Patent Information and Documentation Unit (PIDU) located within 
the Caribbean Documentation Centre of ECLAC, Port-of-Spain, which has 
been established to serve CDCC member countries on matters regarding 
patents.
The host country, Cuba, informed participants about the system 
regarding industrial property as it pertains to that country and 
in which the development of products is undertaken by the State.
The cost of purchase of this technology outside Cuba will vary 
according to agreements v;ith individual countries or regional economic 
blocks.
A recoimnendation was also made by Cuba for the establishment of 
a system to exchange technological information»
Policies, plans and strategies have, therefore, assumed extreme, 
importance. Of the many problems, the lack of market information is 
one of the greatest; so too is the ability of local manufacturers 
to meet demand and to assure quality control with respect to the 
safety and efficacy of the drugs produced»
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It was suggested that these problems could be overcome by the 
sharing of market information, increasing regional production through 
co-operation and by enacting appropriate health legislation»
Dr» Balasubramaniani incorporated the topics on "Trends relating 
to Commercial Development of Pharmaceutical Products in the Caribbean" 
and "The Prospects for Strengthening Regional Production on Pharma­
ceuticals in the Caribbean" into one presentation»
On the first topic, the views were expressed that any analysis 
must include a determination of drug requirements of both the public 
and private sectors and that drug formularies were successful only 
Where drug legislation existed» There was, therefore, the need to 
do both for all the Caribbean region, as soon as possible. The 
prospects for* strengthening regional production were summarised.
Discussions on these topics gave rise to a recommendation that 
more and better information about production in the region was needed. 
This took account of the situation where many of the countries 
represented did not know that others were also producing pharmaceuticals
bnd had under-utilized capacity»
A second recommendation was that where existing plants were 
unable to meet the requirements, there was a requirement to identify 
areas where new regional production was needed.
Dr. Balasubramaniam informed the workshop that vaccine production 
was being decreased by the present producers and that perhaps this 
was one area that the region could develop since developing countries 
were in urgent need of vaccines.
In response to a question on the purchasing of raw materials and 
packaging, the Cuban delegation replied that purchases were made 
globally on the basis of tenders from producers of varying scales, 
and were based on a tabulation of national needs. There were still 
some problems to be overcome regarding packaging.
The decision to produce certain drugs as opposed to importing 
them are determined by strict economic analysis, so that drugs which 
for various reasons are too costly to produce are imported.
The view was expressed that any action for regional drug production 
should be aimed at medium and long-term needs with a view to supplying 
the expected future demand for drugs, and that debate on this topic 
should be centred on a strategy for fulfilling these requirements.
Another view was that unless there was a regional rationalisation 
of production, no reduction on a per unit basis could be achieved and 
that local production could be more expensive than the imported product»
The topic on "Imports and National Production in the Pharmaceutical 
Sector; Thé* Case of Cuba” was delivered by Silvia Delgado Ribas of 
MediCuba. This paper dealt with the development by Cuba of its national 
pharmaceutical Industry from a situation where prior to the revolution 
approximately 20,000 pharmaceuticals were imported, to the present 
where the country produces 85 percent of (approximately) 650 drugs 
in their various formulations used in the country»
The mechanisms through which Cuba continues to increase its 
self-sufficiency in the pr'oductlon of pharmaceuticals and plans for 
future development in production capacity both to meet their local 
needs and to take advantage of existing foreing markets were outlined.
Many questions from the other participants to the Cuban delegation 
were raised on this paper, especially with respect to the economic 
profitability of import substitution with locally produced drugs 
as opposed to re-direction of the supply.
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In response to a question on the number of drugs in the Cuban 
iormulary, it was stated that there are approximately 650 basic products 
in approximately 860 fomulations. The list is revised every six months.
The Jamaican delegate explained that her country's formulary for 
drugs in the public sector was divided into a list of vital, essential 
ánd necessary drugs and these were distributed according to the different 
types of public centres using them.
A representative of Cuba responded that Cuba was currently buildihg 
á facility and a research institute for producing vaccines and other 
biological products which should be onstream before 1990.
A Symposium on the Exploration and Utilization of Medicinal Plantfe 
was led by the Cuban delegation. A very comprehensive account of work 
done on this in Cuba in which there are great prospects for TCDC was 
given. The Ministry of Public Health has set up a group to carry out 
research and development in this field which is being done a systematit 
basis by the collection and analysis of all known medicinal plants. I'lie 
botanical, pharmacological, agronomic and phytocheralcal aspects of 
these plants are among the areas of research studied. The three dlrecbions 
of development centre on the local use of popular herbal medicine; the 
establishment of an export industry and the commercial exploitation of 
specific active ingredients.
The representative of CARIllI gave a brief account of the situation 
in Trinidad and Tobago and spoke more specifically of the Natural 
Products Programme of that Institution which, at the present time, has 
developed two products commercially which have been patented locally.
Some advice was offered to any countries establishing any natural products 
industry which should have a multi-purpose plant as well as assured 
qtiallty control. It was Indicated that possibility existed for 
collaboration with other smaller Islands regarding raw materials supply.
The representative of the University of the West Indies in Jamaica 
said that further investigations needed to be carried out on the medicinal 
plants used in that country, though investigations into two had shown the 
beneficial pharmacological uses and that one of these was being further 
developed for international patenting and marketing.
The representative of CARICOM delivered a paper on this topic which 
indicated that while there is a large market for herbal medicines, there 
is a lack of any institutionalised structure for extracting and marketing.
Discussion on the topic revealed a consensus that there was a great 
amount of work being done regionally in this area, but that there was 
a lack of information sharing with the concomitant danger of duplication 
of work and resources.
To improve information sharing, several delegates offered various 
sources such as the action plans and working papers of the UNIDO Workshop 
in Beijing, China in 1982 on the pharmaceutical industry, the work of 
the Commonwealth Science Council, the OAS EUBITROP project (information 
on which could be disseminated through the CCST) and the Caribbean 
Documentation Centre at ECLAC, Port-of-Spain. The Government of Cuba 
offered to supply planting materials of medicinal plants to any 
interested Caribbean countries.
An important point raised was that of the lack of utilization through 
conventional medicines and practitioners of medicinal plants which made , 
prescription risky. This was caused by the scepticism with which they 
were regarded as well as a lack of precise pharmacological information 
on these plants such as active ingredients, dosage levels, counter 
indications, etc.
A paper on the Study of Medicines Manufactured from the Flora and 
Fauna of the Marine Shelf was delivered by Prof. Ruth Henriques, Dean 
of the Pharmacy and Food Faculty of the University of Havana, the 
Director of the Chemistry and Experimental Institute, and President 
of the Cuban Society of Chemistry,
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An overview of work done in this area in Cuba was given. This 
included the names of the extracts and an indication of worldwide 
prpduction as well as the uses of these extracts from marine flora and 
fauna. It appeared the greatest work has been done using extracts 
derived from various algae, corals, sponges and cartlllganeous fish 
notably shark. Work in this area continued to expand and International 
interest in this field continued as was evideitced by the increasing 
number of International organizations giving support to countries 
Involved in this activity.
The delegate from CARIRI expressed interest in obtaining greater 
information than that contained in the summary paper and this request 
was acceded to by the Cuban delegation.
In respect of a request for information from the ECLAC/CCST 
representative for information on work done by the host country on 
reputed therapeutic properties of algae and on antidotes to fish 
poisons, the Cuban delegation replied that work continued to be done 
on algaes but that not much information was available on antidotes.
Dro Balasubramaniam presented a paper on The Identification of 
Research and Development Priorities in the Pharmaceutical Sector in 
which the reasons for the failure of the translation of the results of 
regional research and development (R+D) Institutions into production 
as well as the lack of local investment in R + D  were analysed. Several 
suggestions were made for overcoming these problems.
One of the major concerns arising out of discussions was the lack 
of information and communication among the countries of the region, the 
need for co-operation on research in progress particularly with respect 
to medicinal plants and on the lack of complementarity between research 
work and marketing.
In elaborating the information needed, it was emphasised that this 
dissemination should be speedy and at as low cost as possible.
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In addition to requiring information on laboratory research, the 
need for market information was also stressed especially since this would 
greatly reduce costs with respect to drug sources, availability and latest 
world developments in the field. This would be especially necessary for 
the smaller island states which do not have the base for establishing a 
pharmaceutical industry.
Cuba reiterated its willingness to extend multilateral assistance 
and information to all CDCC member countries in all aspects of the 
pharmaceutical industry where this was needed especially in medicltial 
plants, quality control and packaging.
The discussion on Technical Co-operation among Caribbean Countries 
in the Phamaceutical Sector was led by Dr. George Boyd of CARICOM. A 
brief history of regional co-operation in this field in the English- 
speaking Caribbean was given. This co-operation started with establish­
ment ¿f the Caribbean Regional Drug Testing Facility, the development 
of a system for the pooled procurement of certain drugs, the establishment 
of a Regional Advisory Panel on Pharmaceuticals and continued with 
the proposed establishment of a Caribbean Formulary of Pharmaceuticals, 
a regional pharmaceutical newsletter, a Caribbean Pharmaceutical Centre 
and the development of a Joint Caribbean Association for the Registration 
of Drugs (JOCARD).
The greatest area for technical co-operation was the sharing of 
Information not only among countries through governmental channels but 
especially through personal contact, as it was noted that frequently 
information in a country did not reach the Intended personnel.
Another area of concern was the danger of exchanging one form of 
dependence on transnational pharmaceutical corporations for another.
Mechanisms for technical co-operation among developing countries 
were described by the ECLAG/CCST representative who informed the meeting 
that the TCDC Unit in New York could provide this in addition to the 
ECLAC/CDCC Secretariat in Port-of-Spain, which would assist in identifying 
other sources of TCDC in dealing with requests for assistance„
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RECOMMENDÂTIONS
1, The Workshop recommended that the greatest possible use be made 
of the available knowledge and capacities in the subregion, in 
order to meet rationally, economically and effectively the growing 
demand for medicines in the different countries of the area.
2a The Workshop proposed the establishment of a Programme for Economic 
Co-operation for purchasing of dosage forms, raw materials and 
packaging materials based on international market surveys of 
different areas. ECLAC/CCST Secretariat should be asked to collate 
all such information from countries in the region and act as a 
clearing house for the distribution of information twice a year.
3. The WorJjLshop proposed the convening of a meeting of CDCC member 
states to seek ways for exchanges of technological and industrial 
Information.
4. The Workshop favoured an appropriate and rational use of drugs 
in all fields related to prescribing, control, registration and 
formularies in all member countries in order to facilitate greater 
harmonisation of the pharmaceutical supply system in the region.
5. The Workshop asked that all CDCC member states and relevant regional 
organisations be invited to meetings related to health, nutrition 
and pharmaceutical development in the region.
6. The Workshop favoured the creation of a computerised data bank
on the use of medicinal plants and marine flora and fauna resources 
for all CDCC member countries and an exchange of materials needed 
from selected species. The ECLAC/CCST Secretariat should contact 
the member states on the location of the Data Bank and strengthening 
any existing data bank in the region.
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7. CDCC member states should study the possibility of establishing
co-operation mechanisms for the production of finished drugs. The 
CDCC Secretariat should co-ordinate the relevant contacts 
according t<? the countries’ interests.
8^  The Workshop recommended that ECLAC/CCST Secretariat make regional 
development forecasts based on specialized studies of relevant 
disciplines to allow for a multi-disciplinary development of the 
Medico-Pharmaceutical Industry on a short, medium and long-term 
basis, for which the necessary information should be requested 
from CDCC member stages.
9« The Workshop suggested that ECLAC/CCST provide on a continuing 
basis sources of information and information dissemination 
mechanisms relq.ting to the pharmaceutical sector both regionally 
and internationally.
lOo The Workshop identified as, priority areas in research and develop­
ment for the region: medicinal plants, dosage forms, packaging
material and quality control of drugs.
11. The Workshop recommended that the Secretariat of ECLAC/CCST
take the appropriate steps to obtain the financial assistance 
needed from the various United Nations agencies, such as WHO, 
UNICEF, UNIDO, UNESCO and other intergovernmental agencies, 
in order to implement the recommendations adopted in the 
Workshop designed to strengthen the co-operation that is required<.
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LIST OF PARTICIPANTS
BARBADOS Tarli DeV» Archer
Permanent Secretary (Social Security) 
Ministry of Health and Social Security 
Jemmotts Lane
Sto Michael Tel; 4260416
Lennox Prescod
Director
■Barbados Drug Service 
Jemmotts Lane
Sto Michael Tel: 4278719/8309
CUBA Epifanio Selman-Housein Abdo 
Dr, en Farmacia, Investigador Titular 
Director de Ciencia y Tecnica 
Union Industrial de Empresas de 
la Industria Medico Farmaceutico 
Ave. 43 Esp. 18A No. 1809 Playa 
Havana Tel: 296977
Felipe Martinez Gordo 
Ingeniero Industrial 
Jefe, Departamento de Colaboración 
Unión Industrial de Empresas de 
la Industria Medico Farmaceutico 
Ave, 43 Esq. 18A No. 1809 Playa 
Havana Tel: 228407
Antonio Padilla Rubiera
Investigador Titular, Especialista en el 
Desarrollo de los Productos Naturales
Empresa Laboratorio Farmacéutico 
"Dr. Mario Muñoz"
Ministerio de Salud Pública 
Hacendados No.l, Municipio 
Havana Vieja Tei: 93305
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Marlene Porto Verdecía 
Lie. en Bioquímica, Farmaceutica 
Investigador Agregado 
Directora Laboratorios Técnicos 
de Medicamentos
Union Industrial de Empresas de 
la Industria Medico Farmaceutico 
Calle 19 de mayo Esq. Amezaga No. 2621 
Plaza de la Revolución 
Havana Tel; 75256
Ocllia Rodríguez Rodríguez 




Havana Vieja Tel: 66105
Berta Zayas Vega
Dra« en Farmacia
Directora de Farmacia y Optica
Ministerio de Salud Publica
Calle 23, Esq. N., Vedado
Havana Tel: 224229
Ruth Daisy Henríques Rodríguez 
Decano Facultad Farmacia y Alimento 
Universidad de Havana, Profesor Titular 
Directora Instituto de Química y 
Biologia Experimental 
26 No. 1605 y San Lazaro y L 
Havana Tel: 7-3542/46-3303
Mirtha Barquet Farah 
Funcionarla
Comité Estatal de Colaboración Económica
Ira. entre A y B, Vedado
Havana Tel: 34019
GUYANA Hazel Moffet-Frank 
Chief Pharmacist Ag,




JAMAICA Hermine María Metcalfe 
Chief Pharmacist 
Ministry of Health 
10 Caledonia Avenue 
Kingston 5 Tel: 9268794/9269220-9
MONTSERRAT Randolph Riley 
Senior Pharmacist 
Glendon Hospital 
P^O Box 24 
Plymouth Tel: 2552
NETHERLANDS ANTILLES Peter HoM« Fontilus 





SAINT LUCIA - Elaine Larcher 
Pharmacist 
Ministry of Health 
Chausee Road 
Castries Tel: 24900
SURINAME Ernie Adolf Brünings 
Chairman of the Board of the
Anton de Kom University of Suriname 
Biologist
Adek University of Suriname/Leysweg 
Paramaribo Tel: 60200
Basdew Sharma
Pharmacist, Production Manager 






















CARIRI Mary (Maura) P« Imbert 
Programme Leader 
'Natural Products
Caribbean Industrial Research Institute (CARIRI)
UWI Campus 
Sto Augustine
TRINIDAD AND TOBAGO Tel: 662-7161-4
UNIVERSITY OF THE 
WEST INDIES " Ronald Kingsley Bourne 
Pharmacologist/Lec turer 
Department of Pharmacology 
University of the West Indies 
Mona
JAMAICA Tel: 9276661 - Ext» 466
9275906
ECLAC Donatus Sto Aimée 
Economic Affairs Officer 
Science and Technology (aoi.)
ECLAC Subregional Headquarters for the Caribbean
PoO Box 1113 
Port-of-Spain
TRINIDAD AND TOBAGO Tel: 623-5595/5428







WORK PROGRAMME OF THE TECHNICAL COMMITTEE 
FOR HEALTH, NUTRITION AND PHARMACEUTICALS 
OF THE CDCC FOR THE 1986-87 PERIOD
1. The Committee shall promote the implementation of the recommendations 
of the Workshop on Pharmaceuticals that was held in Havana,
14-18 March 1986 and those that stem from the mandates of the tenth 
session of the CDCC, relating to the pharmaceutical sector, which 
will be held in Cuba in April 1986, It should also consider the 
recommendations of the Workshop on the Purchasing of Drugs, which 
will be held in Barbados from 28 April - 2 May 1986, and the Third 
Symposium on Medicinal Plants, which will be held in Havana in 
May 1986.
2, In that respect, the Committee should promote the implementation 
of specific actions relating to the development of technical 
assistance in training, the transfer of technologies, market 
studies and the purchasing of inputs, raw materials and other 
basic elements.
3o The Committee should also supply methodological and standardization 
elements chat will make it possible to carry out joint research 
in order to provide answers for the areas to which top priority 
has been assigned;
(a) research in medicinal plants




4o The Committee should promote studies to determine the need for 
drugs and ways of meeting that demand with the help of economic 
and scientific-technical co-operation especially relating to:
(a) the rational use of drugs
(b) the control and registration of drugs, and
(c) the production of finished drugs
5^  Likewise, technological and industrial information relating to 
health, nutrition and pharmaceuticals should be guaranteed and 
exchanged. In this regard, the Committee shall inform the 
Caribbean Documentation Centre of Its willingness to contribute 
to the improvement of its information systems and the Integral 
use of the Information obtained from patents and other sources.
6o The Committee should consider the recommendations arising out of
the Seminars on Patents that the World Intellectual Property
Organization (WIPO) and the ECLAC Secretariat will hold in 1986,
*
7. The Committee will promote an inventory of Research in Progress 
and of the infrastructure of the institutions in line with the 
recommendations of the seminar on the subject that was held in 
Port-of-Spain in January 1986 sponsored by UNESCO and the 
ECLAC Secretariat.
8. The Committee should hold a workshop on primary health care 
in the Caribbean at its second meeting in February 1987 and 
hold a workshop on food and nutrition in the latter half of 1987.
9o The Committee should attempt to evaluate the implementation of 
the recommendations of the Workshop held in Cuba in March 1986 
at the next meeting of the pharmaceutical sector to be held not 
later than 1989.


